Floatz logo

TESTOSTERONE UNDECYLATE

Prostatic Hyperplasia

University of FlorenceSmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Prostatic Hyperplasia cohort.

Asset / SponsorPhaseRating
DINITROGEN MONOXIDE
Beth Israel Deaconess Medical Center
Phase 4BB
AVOLVE
Turku University Hospital
Phase 4BB
Oxygen
Beth Israel Deaconess Medical Center
Phase 4BB
DICLOFENAC
Taha Uçar
Phase 4BB
Jalyn
Dr. J. Curtis Nickel
Phase 3B

View all 17 →

Same molecule, other indications

TESTOSTERONE UNDECYLATE is also rated in:

hypogonadotropic hypogonadismDormant
A
Indicative ·
82 / 100
View asset →
type 2 diabetes mellitusDormant
BBB
Indicative ·
73 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →